Therapeutic Decision Making in Hepatocellular Carcinoma According to Age and Child–Pugh Class: A Nationwide Cohort Analysis in South Korea

Background. We sought to analyze the preferred treatment modality by age and liver function in South Korea. Methods. The Korean Liver Cancer Study Group randomly extracted the data of patients with hepatocellular carcinoma (HCC) enrolled in the Korean Central Cancer Registry from 2008 to 2014 from a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Canadian Journal of Gastroenterology and Hepatology Jg. 2021; H. 1; S. 1 - 7
Hauptverfasser: Park, Sunmin, Rim, Chai Hong, Jung, Young Kul, Yoon, Won Sup
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Egypt Hindawi 2021
Hindawi Limited
John Wiley & Sons, Inc
Wiley
Schlagworte:
ISSN:2291-2789, 2291-2797, 2291-2797
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Background. We sought to analyze the preferred treatment modality by age and liver function in South Korea. Methods. The Korean Liver Cancer Study Group randomly extracted the data of patients with hepatocellular carcinoma (HCC) enrolled in the Korean Central Cancer Registry from 2008 to 2014 from approximately 50 hospitals nationwide. After excluding distant and lymphatic metastases, the treatment preference for patients with a single lesion (excluding PVT (portal vein thrombosis), hepatic vessels, and bile duct invasion) and with PVT was evaluated in 7559 patients. Patients were grouped by age, and baseline liver function was divided based on the Child–Pugh class (CPC) A, B, and C. Results. For a single HCC, the majority of patients selected transarterial therapy as the initial treatment, followed by surgical resection and local ablative therapy. The surgical resection rate decreased significantly with age (p<0.001), and the transarterial therapy rate significantly increased (p<0.001). For CPC C, liver transplantation was significantly increased to 11.5%, and 36.3% of patients received no treatment. In HCC with PVT, the transarterial therapy rate was the highest, followed by the rate of abandonment of treatment. The proportion of no treatment significantly increased with age (p<0.001). In CPC C, transarterial therapy and systemic therapy were attempted in 15.4% and 5.8% of patients, respectively. Conclusions. Age and liver function have a significant impact on the therapeutic decision-making of HCC patients in Korea. In unfavorable conditions, surgical resection was less favored in patients with single tumors, and no treatment was preferred in patients with PVT.
AbstractList Background . We sought to analyze the preferred treatment modality by age and liver function in South Korea. Methods . The Korean Liver Cancer Study Group randomly extracted the data of patients with hepatocellular carcinoma (HCC) enrolled in the Korean Central Cancer Registry from 2008 to 2014 from approximately 50 hospitals nationwide. After excluding distant and lymphatic metastases, the treatment preference for patients with a single lesion (excluding PVT (portal vein thrombosis), hepatic vessels, and bile duct invasion) and with PVT was evaluated in 7559 patients. Patients were grouped by age, and baseline liver function was divided based on the Child–Pugh class (CPC) A , B , and C . Results . For a single HCC, the majority of patients selected transarterial therapy as the initial treatment, followed by surgical resection and local ablative therapy. The surgical resection rate decreased significantly with age ( p < 0.001), and the transarterial therapy rate significantly increased ( p < 0.001). For CPC C, liver transplantation was significantly increased to 11.5%, and 36.3% of patients received no treatment. In HCC with PVT, the transarterial therapy rate was the highest, followed by the rate of abandonment of treatment. The proportion of no treatment significantly increased with age ( p < 0.001). In CPC C, transarterial therapy and systemic therapy were attempted in 15.4% and 5.8% of patients, respectively. Conclusions . Age and liver function have a significant impact on the therapeutic decision‐making of HCC patients in Korea. In unfavorable conditions, surgical resection was less favored in patients with single tumors, and no treatment was preferred in patients with PVT.
We sought to analyze the preferred treatment modality by age and liver function in South Korea. The Korean Liver Cancer Study Group randomly extracted the data of patients with hepatocellular carcinoma (HCC) enrolled in the Korean Central Cancer Registry from 2008 to 2014 from approximately 50 hospitals nationwide. After excluding distant and lymphatic metastases, the treatment preference for patients with a single lesion (excluding PVT (portal vein thrombosis), hepatic vessels, and bile duct invasion) and with PVT was evaluated in 7559 patients. Patients were grouped by age, and baseline liver function was divided based on the Child-Pugh class (CPC) , , and . For a single HCC, the majority of patients selected transarterial therapy as the initial treatment, followed by surgical resection and local ablative therapy. The surgical resection rate decreased significantly with age ( < 0.001), and the transarterial therapy rate significantly increased ( < 0.001). For CPC C, liver transplantation was significantly increased to 11.5%, and 36.3% of patients received no treatment. In HCC with PVT, the transarterial therapy rate was the highest, followed by the rate of abandonment of treatment. The proportion of no treatment significantly increased with age ( < 0.001). In CPC C, transarterial therapy and systemic therapy were attempted in 15.4% and 5.8% of patients, respectively. Age and liver function have a significant impact on the therapeutic decision-making of HCC patients in Korea. In unfavorable conditions, surgical resection was less favored in patients with single tumors, and no treatment was preferred in patients with PVT.
We sought to analyze the preferred treatment modality by age and liver function in South Korea.BackgroundWe sought to analyze the preferred treatment modality by age and liver function in South Korea.The Korean Liver Cancer Study Group randomly extracted the data of patients with hepatocellular carcinoma (HCC) enrolled in the Korean Central Cancer Registry from 2008 to 2014 from approximately 50 hospitals nationwide. After excluding distant and lymphatic metastases, the treatment preference for patients with a single lesion (excluding PVT (portal vein thrombosis), hepatic vessels, and bile duct invasion) and with PVT was evaluated in 7559 patients. Patients were grouped by age, and baseline liver function was divided based on the Child-Pugh class (CPC) A, B, and C.MethodsThe Korean Liver Cancer Study Group randomly extracted the data of patients with hepatocellular carcinoma (HCC) enrolled in the Korean Central Cancer Registry from 2008 to 2014 from approximately 50 hospitals nationwide. After excluding distant and lymphatic metastases, the treatment preference for patients with a single lesion (excluding PVT (portal vein thrombosis), hepatic vessels, and bile duct invasion) and with PVT was evaluated in 7559 patients. Patients were grouped by age, and baseline liver function was divided based on the Child-Pugh class (CPC) A, B, and C.For a single HCC, the majority of patients selected transarterial therapy as the initial treatment, followed by surgical resection and local ablative therapy. The surgical resection rate decreased significantly with age (p < 0.001), and the transarterial therapy rate significantly increased (p < 0.001). For CPC C, liver transplantation was significantly increased to 11.5%, and 36.3% of patients received no treatment. In HCC with PVT, the transarterial therapy rate was the highest, followed by the rate of abandonment of treatment. The proportion of no treatment significantly increased with age (p < 0.001). In CPC C, transarterial therapy and systemic therapy were attempted in 15.4% and 5.8% of patients, respectively.ResultsFor a single HCC, the majority of patients selected transarterial therapy as the initial treatment, followed by surgical resection and local ablative therapy. The surgical resection rate decreased significantly with age (p < 0.001), and the transarterial therapy rate significantly increased (p < 0.001). For CPC C, liver transplantation was significantly increased to 11.5%, and 36.3% of patients received no treatment. In HCC with PVT, the transarterial therapy rate was the highest, followed by the rate of abandonment of treatment. The proportion of no treatment significantly increased with age (p < 0.001). In CPC C, transarterial therapy and systemic therapy were attempted in 15.4% and 5.8% of patients, respectively.Age and liver function have a significant impact on the therapeutic decision-making of HCC patients in Korea. In unfavorable conditions, surgical resection was less favored in patients with single tumors, and no treatment was preferred in patients with PVT.ConclusionsAge and liver function have a significant impact on the therapeutic decision-making of HCC patients in Korea. In unfavorable conditions, surgical resection was less favored in patients with single tumors, and no treatment was preferred in patients with PVT.
Author Jung, Young Kul
Yoon, Won Sup
Rim, Chai Hong
Park, Sunmin
AuthorAffiliation 1 Department of Radiation Oncology, Korea University Ansan Hospital, Ansan, Gyeonggi-do, Republic of Korea
2 Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Gyeonggi-do, Republic of Korea
AuthorAffiliation_xml – name: 1 Department of Radiation Oncology, Korea University Ansan Hospital, Ansan, Gyeonggi-do, Republic of Korea
– name: 2 Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Gyeonggi-do, Republic of Korea
Author_xml – sequence: 1
  givenname: Sunmin
  orcidid: 0000-0002-9371-9529
  surname: Park
  fullname: Park, Sunmin
  organization: Department of Radiation OncologyKorea University Ansan HospitalAnsanGyeonggi-doRepublic of Koreakumc.or.kr
– sequence: 2
  givenname: Chai Hong
  orcidid: 0000-0001-7431-4588
  surname: Rim
  fullname: Rim, Chai Hong
  organization: Department of Radiation OncologyKorea University Ansan HospitalAnsanGyeonggi-doRepublic of Koreakumc.or.kr
– sequence: 3
  givenname: Young Kul
  orcidid: 0000-0002-6566-1382
  surname: Jung
  fullname: Jung, Young Kul
  organization: Division of Gastroenterology and HepatologyDepartment of Internal MedicineKorea University Ansan HospitalAnsanGyeonggi-doRepublic of Koreakumc.or.kr
– sequence: 4
  givenname: Won Sup
  orcidid: 0000-0002-6098-1993
  surname: Yoon
  fullname: Yoon, Won Sup
  organization: Department of Radiation OncologyKorea University Ansan HospitalAnsanGyeonggi-doRepublic of Koreakumc.or.kr
BackLink https://cir.nii.ac.jp/crid/1872835443051671680$$DView record in CiNii
https://www.ncbi.nlm.nih.gov/pubmed/33505941$$D View this record in MEDLINE/PubMed
BookMark eNp9ks1u1DAQgCNUREvpjTOyBAckWGo7jmP3gLQKP60oPxLlbE0cZ-Mlay92QtUbD8CNN-RJcLrbilaCi23Znz-PZ-Z-tuO8M1n2kOAXhBTFIcWUHHLOMKHkTrZHqSQzWspy53ot5G52EOMS48QUhczpvWw3zwtcSEb2sp9nnQmwNuNgNXpltI3WO_Qevlq3QNahY7OGwWvT92MPAVUQtHV-BWiutQ_NRA0ezRcGgWtQ1dm--f3j16dx0aGqhxiP0Bx9gCFJz21jUOU7HwY0d9BfRBunFz77cejQOx8MPMjuttBHc7Cd97Mvb16fVcez049vT6r56UxzLIcZ06Kumc4BSmokKTkYI6cUUA1cCokp5yJnLWBJBZSiZrVsDJC2aYHxkuT72cnG23hYqnWwKwgXyoNVlxs-LBSElJDeKEaalhFmaoI5I0bUjQBJOaOMtUKXOrleblzrsV6ZRhs3BOhvSG-eONuphf-uSkEIkzQJnm4FwX8bTRzUysYp4eCMH6OiTKT_5JjxhD6-hS79GFIuJ6oUeSEKPAkf_R3RdShXRU8A3QA6-BiDaZW2w2WNUoC2VwSrqbnU1Fxq21zp0vNbl668_8CfbHBnbdJPIxElTTEyluOCpDJwgRP2bIN11jVwbv8v_QMzF-Yk
CitedBy_id crossref_primary_10_1097_SLA_0000000000004936
Cites_doi 10.1111/liv.12818
10.1177/1756283x15618129
10.1016/j.diii.2018.03.003
10.1016/j.ejca.2018.09.031
10.21873/invivo.11618
10.1016/j.jhep.2016.07.020
10.1186/s12893-018-0444-x
10.1016/j.suronc.2018.07.009
10.3904/kjim.2015.112
10.4143/crt.2018.687
10.1186/s12885-018-4144-9
10.1111/liv.13357
10.1002/hep.29086
10.4143/crt.2019.138
10.1111/liv.13191
10.1001/jamaoncol.2017.5847
10.1111/jgh.13848
10.6004/jnccn.2019.0019
10.1177/000313481808400238
10.1080/17474124.2018.1517045
10.1016/j.jhep.2018.03.019
10.1155/2019/2141859
10.1016/j.jhep.2016.09.008
10.18632/oncotarget.15075
10.3348/kjr.2014.15.4.464
10.1111/ggi.12747
10.3350/cmh.2017.0112
10.17998/jlc.20.1.41
10.1371/journal.pone.0112184
10.1002/cncr.30237
10.1016/s1470-2045(16)30569-1
10.1093/annonc/mdy308
10.1007/s00330-017-5166-4
10.1007/s12072-017-9799-9
ContentType Journal Article
Copyright Copyright © 2021 Sunmin Park et al.
Copyright © 2021 Sunmin Park et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0
Copyright © 2021 Sunmin Park et al. 2021
Copyright_xml – notice: Copyright © 2021 Sunmin Park et al.
– notice: Copyright © 2021 Sunmin Park et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0
– notice: Copyright © 2021 Sunmin Park et al. 2021
DBID RHU
RHW
RHX
RYH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
8FQ
8FV
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
Q9U
7X8
5PM
DOA
DOI 10.1155/2021/6640121
DatabaseName Hindawi Publishing Complete
Hindawi Publishing Subscription Journals
Hindawi Publishing Open Access
CiNii Complete
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Canadian Business & Current Affairs Database
Canadian Business & Current Affairs Database (Alumni)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
ProQuest Central Premium
ProQuest One Academic
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central
CBCA Complete (Alumni Edition)
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
CBCA Complete
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef

Publicly Available Content Database

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: RHX
  name: Hindawi Publishing Open Access
  url: http://www.hindawi.com/journals/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: PIMPY
  name: ProQuest Publicly Available Content
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2291-2797
Editor Granito, Alessandro
Editor_xml – sequence: 1
  givenname: Alessandro
  surname: Granito
  fullname: Granito, Alessandro
EndPage 7
ExternalDocumentID oai_doaj_org_article_41df414eb10641e8bd8a9264244f8c7c
PMC7811492
33505941
10_1155_2021_6640121
Genre Journal Article
GeographicLocations Republic of Korea
South Korea
GeographicLocations_xml – name: Republic of Korea
– name: South Korea
GrantInformation_xml – fundername: Korea University Ansan Hospital
  grantid: O1903621; K2010971
GroupedDBID 3V.
53G
5VS
7X7
88E
8FI
8FJ
8FQ
AAFWJ
AAJEY
ABUWG
ADBBV
AFKRA
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
DWQXO
EBD
EBS
EMOBN
FYUFA
GROUPED_DOAJ
HMCUK
HYE
IAO
ICQ
IEA
IHR
IHW
INH
ITC
M1P
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RHU
RHW
RHX
RPM
SV3
UKHRP
0R~
24P
AAMMB
ACCMX
AEFGJ
AFFHD
AGXDD
AIDQK
AIDYY
ALUQN
PHGZM
PHGZT
PJZUB
PPXIY
RYH
AAYXX
CITATION
EJD
H13
IPNFZ
RIG
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
AZQEC
K9.
PKEHL
PQEST
PQUKI
Q9U
7X8
5PM
ID FETCH-LOGICAL-c609t-4c8bb4c3aa72e9176aee940122ca69890266834fa0928a78b4b9dea1fdfa46713
IEDL.DBID RHX
ISICitedReferencesCount 2
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000609876900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2291-2789
2291-2797
IngestDate Fri Oct 03 12:52:02 EDT 2025
Tue Nov 04 01:50:50 EST 2025
Fri Jul 11 06:45:00 EDT 2025
Sat Nov 29 14:45:08 EST 2025
Thu Jan 02 22:32:58 EST 2025
Tue Nov 18 22:44:17 EST 2025
Sat Nov 29 07:26:54 EST 2025
Mon Nov 10 09:14:18 EST 2025
Sun Jun 02 19:15:29 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright © 2021 Sunmin Park et al.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c609t-4c8bb4c3aa72e9176aee940122ca69890266834fa0928a78b4b9dea1fdfa46713
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Academic Editor: Alessandro Granito
ORCID 0000-0002-6098-1993
0000-0002-6566-1382
0000-0002-9371-9529
0000-0001-7431-4588
OpenAccessLink https://dx.doi.org/10.1155/2021/6640121
PMID 33505941
PQID 2478358502
PQPubID 2032234
PageCount 7
ParticipantIDs doaj_primary_oai_doaj_org_article_41df414eb10641e8bd8a9264244f8c7c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7811492
proquest_miscellaneous_2482663046
proquest_journals_2478358502
pubmed_primary_33505941
crossref_citationtrail_10_1155_2021_6640121
crossref_primary_10_1155_2021_6640121
nii_cinii_1872835443051671680
hindawi_primary_10_1155_2021_6640121
PublicationCentury 2000
PublicationDate 2021-00-00
PublicationDateYYYYMMDD 2021-01-01
PublicationDate_xml – year: 2021
  text: 2021-00-00
PublicationDecade 2020
PublicationPlace Egypt
PublicationPlace_xml – name: Egypt
– name: Oakville
PublicationTitle Canadian Journal of Gastroenterology and Hepatology
PublicationTitleAlternate Can J Gastroenterol Hepatol
PublicationYear 2021
Publisher Hindawi
Hindawi Limited
John Wiley & Sons, Inc
Wiley
Publisher_xml – name: Hindawi
– name: Hindawi Limited
– name: John Wiley & Sons, Inc
– name: Wiley
References e_1_2_9_30_2
e_1_2_9_10_2
e_1_2_9_33_2
e_1_2_9_34_2
e_1_2_9_12_2
e_1_2_9_31_2
e_1_2_9_11_2
e_1_2_9_32_2
e_1_2_9_14_2
e_1_2_9_13_2
e_1_2_9_16_2
e_1_2_9_35_2
e_1_2_9_15_2
e_1_2_9_36_2
e_1_2_9_18_2
e_1_2_9_17_2
e_1_2_9_19_2
e_1_2_9_21_2
e_1_2_9_20_2
e_1_2_9_23_2
e_1_2_9_7_2
e_1_2_9_6_2
e_1_2_9_5_2
Korean Sirlin (e_1_2_9_4_2) 2018; 13
e_1_2_9_3_2
e_1_2_9_2_2
e_1_2_9_1_2
e_1_2_9_9_2
e_1_2_9_8_2
e_1_2_9_25_2
e_1_2_9_24_2
e_1_2_9_27_2
e_1_2_9_26_2
Chen H. (e_1_2_9_22_2) 2020; 22
e_1_2_9_29_2
e_1_2_9_28_2
References_xml – ident: e_1_2_9_26_2
  doi: 10.1111/liv.12818
– ident: e_1_2_9_33_2
  doi: 10.1177/1756283x15618129
– ident: e_1_2_9_12_2
  doi: 10.1016/j.diii.2018.03.003
– ident: e_1_2_9_32_2
  doi: 10.1016/j.ejca.2018.09.031
– ident: e_1_2_9_25_2
  doi: 10.21873/invivo.11618
– ident: e_1_2_9_30_2
  doi: 10.1016/j.jhep.2016.07.020
– ident: e_1_2_9_23_2
  doi: 10.1186/s12893-018-0444-x
– ident: e_1_2_9_21_2
  doi: 10.1016/j.suronc.2018.07.009
– ident: e_1_2_9_15_2
  doi: 10.3904/kjim.2015.112
– ident: e_1_2_9_36_2
  doi: 10.4143/crt.2018.687
– volume: 13
  start-page: 227
  year: 2018
  ident: e_1_2_9_4_2
  article-title: Korean liver cancer association-national cancer center Korea practice guidelines for the management of hepatocellular carcinoma
  publication-title: Gut Liver
– ident: e_1_2_9_31_2
  doi: 10.1186/s12885-018-4144-9
– ident: e_1_2_9_27_2
  doi: 10.1111/liv.13357
– ident: e_1_2_9_3_2
  doi: 10.1002/hep.29086
– ident: e_1_2_9_7_2
  doi: 10.4143/crt.2019.138
– ident: e_1_2_9_19_2
  doi: 10.1111/liv.13191
– ident: e_1_2_9_18_2
  doi: 10.1001/jamaoncol.2017.5847
– ident: e_1_2_9_11_2
  doi: 10.1111/jgh.13848
– ident: e_1_2_9_1_2
  doi: 10.6004/jnccn.2019.0019
– ident: e_1_2_9_13_2
  doi: 10.1177/000313481808400238
– ident: e_1_2_9_24_2
  doi: 10.1080/17474124.2018.1517045
– ident: e_1_2_9_2_2
  doi: 10.1016/j.jhep.2018.03.019
– ident: e_1_2_9_17_2
  doi: 10.1155/2019/2141859
– ident: e_1_2_9_35_2
  doi: 10.1016/j.jhep.2016.09.008
– ident: e_1_2_9_16_2
  doi: 10.18632/oncotarget.15075
– ident: e_1_2_9_34_2
  doi: 10.3348/kjr.2014.15.4.464
– ident: e_1_2_9_20_2
  doi: 10.1111/ggi.12747
– ident: e_1_2_9_10_2
  doi: 10.3350/cmh.2017.0112
– ident: e_1_2_9_29_2
  doi: 10.17998/jlc.20.1.41
– ident: e_1_2_9_8_2
  doi: 10.1371/journal.pone.0112184
– ident: e_1_2_9_9_2
  doi: 10.1002/cncr.30237
– volume: 22
  year: 2020
  ident: e_1_2_9_22_2
  article-title: Multicenter analysis of long-term oncologic outcomes of hepatectomy for elderly patients with hepatocellular carcinoma
  publication-title: HPB (Oxford)
– ident: e_1_2_9_28_2
  doi: 10.1016/s1470-2045(16)30569-1
– ident: e_1_2_9_5_2
  doi: 10.1093/annonc/mdy308
– ident: e_1_2_9_14_2
  doi: 10.1007/s00330-017-5166-4
– ident: e_1_2_9_6_2
  doi: 10.1007/s12072-017-9799-9
SSID ssj0001255932
ssib061642070
ssib031740937
ssib027512388
ssib050729851
Score 2.276073
Snippet Background. We sought to analyze the preferred treatment modality by age and liver function in South Korea. Methods. The Korean Liver Cancer Study Group...
Background . We sought to analyze the preferred treatment modality by age and liver function in South Korea. Methods . The Korean Liver Cancer Study Group...
We sought to analyze the preferred treatment modality by age and liver function in South Korea. The Korean Liver Cancer Study Group randomly extracted the data...
We sought to analyze the preferred treatment modality by age and liver function in South Korea.BackgroundWe sought to analyze the preferred treatment modality...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
nii
hindawi
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1
SubjectTerms Ablation
Age
Cancer therapies
Carcinoma, Hepatocellular
Carcinoma, Hepatocellular - epidemiology
Carcinoma, Hepatocellular - therapy
Chemotherapy
Cohort analysis
Cohort Studies
Decision Making
Diseases of the digestive system. Gastroenterology
Hepatitis
Humans
Liver cancer
Liver Neoplasms
Liver Neoplasms - therapy
Metastasis
Patients
Portal Vein
Radiation therapy
RC799-869
Republic of Korea
Retrospective Studies
Thrombosis
Treatment Outcome
Tumors
Veins & arteries
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQVSEuiPIZaJGRyglFjR07trktC1Ul1KqHIvUWObbTjVQStM3SKz-AW_9hfwkzTnbZRaBeuOSQWHIyM_Gb8cd7hOybwtisljLVtfSpAABMq5DL1AepTPDSWlZHsQl1cqLPz83pmtQX7gkb6IEHwx0I5mvBBAwpAJ4s6MprawDFAZZq7ZTD0ReynrViaphdgUw5qpNxbliKxz2Xu96lxIKfHRSFQD6zDTyKtP2QCc-wHr5uAG_apvlb7vnnFso1TDp8RB6OySSdDB-xQ-6F9jG5fzwulz8hP89-n66iH0c1HXocBaho09IjwKK-w7l73IxKp6gr1HZfLUUNiTmiGu07OrkI1LaeRhbk2x83p4uLGY1imu_phA7E2teND3TazSCZp0ueE-whKvTRzx2kpk_Jl8NPZ9OjdJRfSF2RmT4VTleVcLm1igeo6gobgkGbcWdRdhKqt0LnoraZ4doqXYnK-AC-9bWF4Zflz8hW27XhBaFZwDzGSe65QQDUWQjKVLljyjupeELeLZ1QupGbHCUyLstYo0hZosvK0WUJebtq_W3g5PhHuw_oz1UbZNKONyC-yjG-yrviKyH7YzTc0dcehAq8PF6ZVkhjJ5BOjYElCp0lZHcZROU4SlyVXOC8m5YZGODN6jH83-h424ZugW2gACxw_Tohz4eYW71Inkuk24HO1UY0bnzx5pO2mUUOcTxgLAx_-T9M9Io8QFMME1O7ZKufL8Ie2Xbf--Zq_jr-mL8AMT013A
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZgi1AvvB-BFhmpnFDUxLETmwvaLq0qoa5WqEi9RY7t7EaCpN0HvfIDuPEP-SXMeL3bLuJx4LKHjSXb8WTmm7H9fYTsqVzppBYilrWwMYcAGFcuE7F1olDOCq3T2otNFMOhPDtTo1Bwm4VjlSuf6B217QzWyPcZxxqFFAl7e34Ro2oU7q4GCY2bZAuZyniPbB0cDkcfrlVZADF7lTLGVBrjtc_V6XchMPFP9_OcI6_ZRlzy9P2AiCeYF182EHfapvkdBv31KOW12HR0939ndY_cCaiU9pdmdJ_cqKcPyO2TsO_-kHw7vbqmRd8FWR564pWsaNPSYwhq8w43AfBUKx2gQFHbfdYUxSimGB7pvKP9saO6tdTTKf_4-n20GE-oV-V8Q_t0ydB92VhHB90EsgK6IkzBHrzUH33fAcZ9RD4eHZ4OjuOg4xCbPFHzmBtZVdxkWhfMQXqYa-cUvnRmNOpXQhqYy4zXOlFM6kJWvFLWgZHYWoMfT7PHpNd2rXtKaOIQEBnBLFMYSWXiXKGqzKSFNaJgEXm9WsXSBJJz1Nr4VPpkR4gS17wMax6RV-vW50tyjz-0O0CDWLdBSm7_Rzcdl-ELL3lqa55yiH2A8lInKyu1ArgJ-KmWpjAR2Qvm9I--dsHWYPD4m8oC-fA48rKl8CZymURkZ2VJZXA3s_LKjCLycv0YHAUuvG5dt8A2kEnmuBEekSdLo10PJMsE8vZA58WGOW_MePNJ20w8GTneVOaKPfv7sJ6TbZzksna1Q3rz6cLtklvmy7yZTV-Er_YnZjlFmQ
  priority: 102
  providerName: ProQuest
Title Therapeutic Decision Making in Hepatocellular Carcinoma According to Age and Child–Pugh Class: A Nationwide Cohort Analysis in South Korea
URI https://dx.doi.org/10.1155/2021/6640121
https://cir.nii.ac.jp/crid/1872835443051671680
https://www.ncbi.nlm.nih.gov/pubmed/33505941
https://www.proquest.com/docview/2478358502
https://www.proquest.com/docview/2482663046
https://pubmed.ncbi.nlm.nih.gov/PMC7811492
https://doaj.org/article/41df414eb10641e8bd8a9264244f8c7c
Volume 2021
WOSCitedRecordID wos000609876900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2291-2797
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001255932
  issn: 2291-2789
  databaseCode: DOA
  dateStart: 20140101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2291-2797
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssib050729851
  issn: 2291-2789
  databaseCode: M~E
  dateStart: 20140101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Canadian Business & Current Affairs Database
  customDbUrl:
  eissn: 2291-2797
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001255932
  issn: 2291-2789
  databaseCode: 8FQ
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/cbcacomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2291-2797
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001255932
  issn: 2291-2789
  databaseCode: 7X7
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2291-2797
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001255932
  issn: 2291-2789
  databaseCode: BENPR
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Publicly Available Content
  customDbUrl:
  eissn: 2291-2797
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001255932
  issn: 2291-2789
  databaseCode: PIMPY
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVWIB
  databaseName: Wiley Online Library Open Access
  customDbUrl:
  eissn: 2291-2797
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001255932
  issn: 2291-2789
  databaseCode: 24P
  dateStart: 19870101
  isFulltext: true
  titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLboQGgviDuFrTLSeEIRudixzVtXVhWhVmEaUnmKHNtZI0Ey9cJe-QG88Q_5JZzjpmUdIHix1MSVE5_jnO_48n2EHKlU6bDkPJAltwGDABgULuGBdVwoZ7nWUenFJsRkIqdTlbUkSYvfl_Ah2mF6Hr1KU4bsYx3SkRyd93Q0vTKVArDYS5HFsYoCPNu52eJ-7e87wcdz9APsnWHye1lBcKmr6k9A8_p-ySsBaHiX3GmRI-2vTX2P3HD1fXJ73K6NPyDfzn4dpaJvWukcOvZqU7Sq6QgCz7LBiXrceUoHKCJUN581RcGIOYYwumxo_9xRXVvqKY9_fP2erc5n1CtnvqZ9umbRvqyso4NmBsidbkhNsAUvx0ffNYBDH5IPw5OzwShotRYCk4ZqGTAji4KZRGsRO0jhUu2cwj6LjUaNSUjVUpmwUocqllrIghXKOjCkLTV8a6PkEdmrm9o9ITR0CFoMj22sMNrJ0DmhisREwhou4i55uTFCbloictTD-JT7hITzHE2Wtybrkhfb2hdrAo6_1DtGe27rIG22vwCulLejMGeRLVnEID4BEoucLKzUCiAhYJxSGmG65Kj1hn-0dQiuAg-PZSQFctYx5E6LoCdSGXbJwcaJ8vaTsMhjhpNskofQAc-3t2Ewo-F17ZoV1oFsL8XF6i55vPa57YMkCUduHWhc7Hjjzhvv3qmrmScMx9PETMVP_-_tnpF9_LmeZzoge8v5yh2SW-bLslrMe6QjpsKXEko5fN8jN49PJtlpz09nQDnJxnAtezvOPvb8QP0J3AErXg
linkProvider Hindawi Publishing
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbtQwFLVKQcCG9yPQgpHaFYqaOHFsIyE0TKmmms6oi0HqLjiJMxMJkjIPRuz4AHb8Bx_Fl3Cvk0w7iMeqCzZZJFbsONf35etzCNlRkdJezrkrc565IRhANzEBdzPDhTIZ19rPLdmEGA7lyYk63iDf27MwWFbZ6kSrqLMqxRz5HgsxRyG5x16dfnSRNQp3V1sKjVos-ubzEkK22cvDffi_u4wdvBl1e27DKuCmkafmbpjKJAnTQGvBDAQrkTZGhbjDlGpkU4SgJJJBmGtPMamFTMJEZQaGnOUatIofwHsvkcugxwWWkIkTcS6nA_655URjTPkuHjJta-05xzSDvxdF2JW_ZgUtWQD43xOMwpcFWLmyKH7n8f5auHnOEh7c_N_m8Ba50fjctFMvkttkI5_eIVcHTVXBXfJ1dHYIje43pEN0YHm6aFHSHpjseYVbHFizS7tIv1RWHzRFqo0pGn86r2hnbKguM2rBon98-Xa8GE-o5Rx9QTu0xh9fFpmh3WoCMQ9t4WCwB0tkSPsVePD3yNsLmYv7ZLOsSvOQUM-gu5dyljGFfoL0jBEqCVJfZCkXzCHPW6mJ0wbCHZlE3sc2lOM8RhmLGxlzyO6q9WkNXfKHdq9RAFdtEHDc3qim47jRX3HoZ3noh2DZwYf1jUwyqRU40-Ad5jIVqUN2GvH9R1_bINsweLz6UiDaX4iocz7MRCQ9h2y1khs3ynQWn4mtQ56tHoMaxB-vS1MtsA3EyRFu8zvkQb1IVgMJAo6oRNC5WFs-a1-8_qQsJhZqHc9hh4o9-vuwnpJrvdHgKD46HPYfk-v4wXWWbotszqcLs02upJ_mxWz6xOoLSt5d9OL6Cel3oPQ
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKQRUX3o9AC0ZqTyjaxLETGwmhZZdVq9LVIhWpt-DEzm4kSMo-WHHjB3Dj3_Bz-CXM5LHtIh6nHrjkkIxixxnPfGOP5yNkV4VKe5kQrsyEcTk4QDexgXCNFZGyRmjtZxXZRDQcypMTNdog39uzMJhW2drEylCbMsU18g7juEYhhcc6WZMWMeoPXpx-dJFBCndaWzqNWkUO7eclhG-z5wd9-Nd7jA1eHff23YZhwE1DT81dnsok4WmgdcQsBC6htlZx3G1KNTIrQoASyoBn2lNM6kgmPFHGQvdNpsHC-AG89xK5HAUghqfUB2_Ore8AVq_40RhTvosHTtu8eyFwycHvhCE25a95xIo4ALD4BCPyZQ4er8jz36HfX5M4z3nFwfX_eTxvkGsNFqfdevLcJBvZ9BbZOmqyDW6Tr8dnh9NovyEjokcVfxfNC7oPrnxe4tYH5vLSHtIyFeUHTZGCY4qggM5L2h1bqgtDqyLSP758Gy3GE1pxkT6jXVrXJV_mxtJeOYFYiLZlYrCFiuCQHpaA7O-QtxcyFnfJZlEW9j6hnkUYmApmmEL8ID1rI5UEqR-ZVETMIU9bDYrTprQ7Moy8j6sQT4gY9S1u9M0heyvp07qkyR_kXqIyrmSwEHl1o5yO48auxdw3Gfc5eHzAtr6ViZFaAcgG1JjJNEodstuo8j_a2gE9h87j1ZcRVgHkWI3Oh5EIpeeQ7VaL48bIzuIzFXbIk9VjMI_443VhywXKQPwc4va_Q-7VE2bVkSAQWK0IGo_WptLaF68_KfJJVYIdz2dzxR78vVuPyRbMqfj1wfDwIbmK31sv3m2Tzfl0YXfIlfTTPJ9NH1Wmg5J3Fz23fgKdGanE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Therapeutic+Decision+Making+in+Hepatocellular+Carcinoma+According+to+Age+and+Child%E2%80%93Pugh+Class%3A+A+Nationwide+Cohort+Analysis+in+South+Korea&rft.jtitle=Canadian+journal+of+gastroenterology+%26+hepatology&rft.au=Park%2C+Sunmin&rft.au=Rim%2C+Chai+Hong&rft.au=Jung%2C+Young+Kul&rft.au=Yoon%2C+Won+Sup&rft.date=2021&rft.pub=Hindawi&rft.issn=2291-2789&rft.eissn=2291-2797&rft.volume=2021&rft_id=info:doi/10.1155%2F2021%2F6640121&rft.externalDocID=10_1155_2021_6640121
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2291-2789&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2291-2789&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2291-2789&client=summon